Tagore's Day' celebration at St Aloysius College on Feb 26

Bengaluru, May 17: Karnataka on Sunday extended lockdown for two days until midnight of Tuesday, May 19. Earlier today, Tamil Nadu and Maharashtra extended the lockdown till May 31. The state government said that the guidelines and norms as followed during Coronavirus Lockdown 3 will remain in place till 19th midnight or till further notice.

Meanwhile, the total number of coronavirus cases in Karnataka rose to 1,146 on Saturday. With 37 deaths and 497 discharges, there are 611 active corona cases in the state. 

Out of 54 new cases, twentytwo are from Mandya, ten from Kalaburagi, six from Hassan, four from Dharwad, three each from Yadgir and Kolar, two each from Dakshina Kannada and Shivamogga, and one each from Udupi and Vijayapura.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.